The Full 2026 Programme for the 16th World ADC London Is Here

The wait is over, the full 2026 programme for the 16th World ADC London has officially been released! As the largest and pre-eminent ADC forum in Europe makes its return, this year’s meeting is set to secure the future of ADCs as standard-of-care therapies with an expanded agenda and an impressive global faculty.

This brand-new programme showcases 120 global presenters from Europe, North America and Asia, delivering content across five scientific end-to-end streams. As a valued member of the ADC community, you’re among the first to get a look at the newly released agenda packed with forward-thinking insights spanning discovery to late-stage manufacturing, designed to maximise the therapeutic index of your ADCs.

Access the brand new full four-day programme here.

Why World ADC London 2026 Should Be in Your Conference Calendar

The 2026 agenda has been meticulously developed to address the most pressing needs and opportunities in ADC innovation. Here’s what makes this event unmissable:

ADC Differentiation Front & Centre

In a landscape marked by validated payload MoA and target crowding, differentiation is key.
The 2026 programme highlights next-generation ADC development across:

  • Novel cytotoxic and non-cytotoxic payloads
  • Dual payload ADCs
  • Bispecific and biparatopic formats
  • Non-antibody and fragment conjugates

This content is specifically designed to help you navigate emerging strategies that will define the next era of ADC therapy.

Screenshot 2025-11-13 083101

Clinician, Regulator & Investor Speakers

This year’s meeting expands beyond industry experts, featuring new voices from:

  • Dana-Farber Cancer Institute
  • Paul Ehrlich Institute
  • Medicxi

These added perspectives bring essential insights into clinical advancement, regulatory expectations and investment priorities for accelerating ADC progression into earlier line patient therapies.

First-Time Presenting Companies

Among the 120+ speakers, the 2026 faculty includes several companies making their World ADC London debut:

  • Adcoris Biopharma
  • CytomX Tx
  • Helix Biopharma
  • Kivu Biosciences
  • Radiance Biopharma
  • Salubris Bio
  • Tubulis

These organisations will showcase their novel ADC candidate design and development, offering attendees exclusive early insights into emerging technologies.

Dive Into Four Days of Unmatched ADC Insights

Screenshot 2025-11-13 083028

The full industry-focused agenda provides a detailed breakdown of content spanning four days of cutting-edge research discussions, technology showcases and unparalleled networking opportunities. Whatever your experience level in the ADC field, World ADC London has you covered.

 

Join Us in London This February

I truly look forward to welcoming you to London in February as we kickstart ADC development into 2026 at the 16th World ADC London.